Skip to main content

Fly’s Blood-Brain Barrier Has Circadian Rhythms

In Drosophila, the tissue is more permeable to drugs at night, offering a possible explanation for why some medicines work better at certain times of day.

Written byAbby Olena, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

Adult fruit fly brain with the blood-brain barrier labeled in greenSHIRLEY ZHANG AND AMITA SEHGALGetting drugs past the blood-brain barrier (BBB) is notoriously difficult, but a study published today (March 8) in Cell offers a potential solution. Researchers found that the Drosophila BBB has a molecular clock that renders it more or less penetrable during certain hours of the day. Indeed, giving the flies a drug for treating seizures at night was more effective than during the day.

The authors “give mechanistic insight for how time-of-day difference in blood-brain barrier permeability comes to be,” says Robert Dallmann, a circadian biologist and pharmacologist at University of Warwick in the United Kingdom who did not participate in the study. “They even show that time of treatment really makes a difference.”

Researchers and clinicians have found that the timing of medical treatments—including vaccines and chemotherapy for brain cancer—can influence their efficacy, but it is still unclear how the circadian clock exerts these effects.

To investigate the permeability of the BBB, a team led by Amita Sehgal of the University of Pennsylvania injected fruit flies with fluorescent dye at four-hour timepoints throughout the day. They found that more of the dye made it into the insects’ brains ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo